PURPOSE: To introduce a revised version of the grading system established by the International ARM Epidemiological Study Group for identifying and quantifying abnormalities of age-related maculopathy (ARM) and age-related degeneration (AMD) and to investigate its reliability, specifically the inter- and intra-observer variability. METHODS: Fifty eyes of 25 patients with ARM or AMD in at least one eye were randomly selected from a large ongoing collection of clinical data and DNA in a tertiary referral UK population. Stereoscopic color fundus photographs were taken with a 30 degrees fundus camera and were centered on the macula. Presence and severity of fundus abnormalities in ARM and AMD were graded using a grid to define macular subfields and standard circles to define the size of lesions. Inter-observer variability was assessed by having three retinal specialists evaluate the color slides and intra-observer variability by re-grading the same set. RESULTS: The inter-observer agreement for all subfields was fair to substantial for small hard drusen (70-89%; kappa=0.26-0.63) and intermediate soft drusen (76-94%; kappa=0.27-0.69). Agreement ranged between 87% and 100%, between 50% and 92%, and between 78% and 100% for larger drusen, the presence of hyperpigmentation, and the presence of hypopigmentation, respectively. Agreement was moderate to almost perfect for the presence of geographic atrophy (88-98%; kappa=0.60-0.95) and substantial to almost perfect for the presence of choroidal neovascularization (84-100%; kappa=0.62-1.00). The intra-observer variability for the grading of drusen characteristics and pigmentary changes was similar in magnitude, but slightly greater for features of advanced AMD. CONCLUSION: Reproducibility was achieved using a revised version of the grading system established by the International ARM Epidemiological Study Group. This grading system may therefore be used for phenotyping of ARM and AMD.
PURPOSE: To introduce a revised version of the grading system established by the International ARM Epidemiological Study Group for identifying and quantifying abnormalities of age-related maculopathy (ARM) and age-related degeneration (AMD) and to investigate its reliability, specifically the inter- and intra-observer variability. METHODS: Fifty eyes of 25 patients with ARM or AMD in at least one eye were randomly selected from a large ongoing collection of clinical data and DNA in a tertiary referral UK population. Stereoscopic color fundus photographs were taken with a 30 degrees fundus camera and were centered on the macula. Presence and severity of fundus abnormalities in ARM and AMD were graded using a grid to define macular subfields and standard circles to define the size of lesions. Inter-observer variability was assessed by having three retinal specialists evaluate the color slides and intra-observer variability by re-grading the same set. RESULTS: The inter-observer agreement for all subfields was fair to substantial for small hard drusen (70-89%; kappa=0.26-0.63) and intermediate soft drusen (76-94%; kappa=0.27-0.69). Agreement ranged between 87% and 100%, between 50% and 92%, and between 78% and 100% for larger drusen, the presence of hyperpigmentation, and the presence of hypopigmentation, respectively. Agreement was moderate to almost perfect for the presence of geographic atrophy (88-98%; kappa=0.60-0.95) and substantial to almost perfect for the presence of choroidal neovascularization (84-100%; kappa=0.62-1.00). The intra-observer variability for the grading of drusen characteristics and pigmentary changes was similar in magnitude, but slightly greater for features of advanced AMD. CONCLUSION: Reproducibility was achieved using a revised version of the grading system established by the International ARM Epidemiological Study Group. This grading system may therefore be used for phenotyping of ARM and AMD.
Authors: Christopher J Hammond; Andrew R Webster; Harold Snieder; Alan C Bird; Clare E Gilbert; Tim D Spector Journal: Ophthalmology Date: 2002-04 Impact factor: 12.079
Authors: E M Stone; A R Webster; K Vandenburgh; L M Streb; R R Hockey; A J Lotery; V C Sheffield Journal: Nat Genet Date: 1998-12 Impact factor: 38.330
Authors: R Allikmets; N F Shroyer; N Singh; J M Seddon; R A Lewis; P S Bernstein; A Peiffer; N A Zabriskie; Y Li; A Hutchinson; M Dean; J R Lupski; M Leppert Journal: Science Date: 1997-09-19 Impact factor: 47.728
Authors: Zohar Yehoshua; Philip J Rosenfeld; Giovanni Gregori; William J Feuer; Manuel Falcão; Brandon J Lujan; Carmen Puliafito Journal: Ophthalmology Date: 2010-10-29 Impact factor: 12.079
Authors: Giovanni Gregori; Zohar Yehoshua; Carlos Alexandre de Amorim Garcia Filho; SriniVas R Sadda; Renata Portella Nunes; William J Feuer; Philip J Rosenfeld Journal: Invest Ophthalmol Vis Sci Date: 2014-10-21 Impact factor: 4.799
Authors: Zhongdi Chu; Yingying Shi; Xiao Zhou; Liang Wang; Hao Zhou; Rita Laiginhas; Qinqin Zhang; Yuxuan Cheng; Mengxi Shen; Luis de Sisternes; Mary K Durbin; William Feuer; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Am J Ophthalmol Date: 2021-11-13 Impact factor: 5.258
Authors: Hendrik P N Scholl; Monika Fleckenstein; Lars G Fritsche; Steffen Schmitz-Valckenberg; Arno Göbel; Christine Adrion; Christine Herold; Claudia N Keilhauer; Friederike Mackensen; Andreas Mössner; Daniel Pauleikhoff; Andreas W A Weinberger; Ulrich Mansmann; Frank G Holz; Tim Becker; Bernhard H F Weber Journal: PLoS One Date: 2009-10-12 Impact factor: 3.240
Authors: Hendrik P N Scholl; Peter Charbel Issa; Maja Walier; Stefanie Janzer; Beatrix Pollok-Kopp; Florian Börncke; Lars G Fritsche; Ngaihang V Chong; Rolf Fimmers; Thomas Wienker; Frank G Holz; Bernhard H F Weber; Martin Oppermann Journal: PLoS One Date: 2008-07-02 Impact factor: 3.240
Authors: Jessica N Cooke Bailey; Joshua D Hoffman; Rebecca J Sardell; William K Scott; Margaret A Pericak-Vance; Jonathan L Haines Journal: J Clin Med Date: 2016-03-04 Impact factor: 4.241